Skip to main content
. Author manuscript; available in PMC: 2015 May 27.
Published in final edited form as: N Engl J Med. 2014 Nov 12;371(22):2072–2082. doi: 10.1056/NEJMoa1405386

Table 2.

Association between the Presence of Inactivating Mutations in NPC1L1 and Plasma Lipid Levels.*

Variable Mean Difference
between Carriers
and Noncarriers*
P Value
Cholesterol (mg/dl)
    Total −13 0.03
    Low-density lipoprotein −12 0.04
    High-density lipoprotein 2 0.29
Triglycerides (% change) −12 0.11
*

The mean difference is the summary effect estimate for carriers of inactivating mutations in NPC1L1, as compared with noncarriers, after adjustment for age, sex, and study. Participants from population-based studies (ARIC, JHS, and WGHS) and controls without coronary heart disease from case–control studies were included in this analysis. To convert the values for cholesterol to millimoles per liter, multiply by 0.02586.

This P value was calculated with the use of natural log transformation of the values.